# Oragenics Inc: Form 10-Q for the period ended Jun 30, 2021

- Company: [Oragenics Inc](/companies/ogen.md) (CIK 1174940)
- Form: 10-Q
- Filed: 2021-08-16
- Accepted by EDGAR: Aug 16, 2021, 16:06 ET
- Period: 2021-06-30
- Accession: 0001493152-21-020152
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1174940/000149315221020152/form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1174940/000149315221020152/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2021-04-01 to 2021-06-30 | $2.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2021-01-01 to 2021-06-30 | $5.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2021-04-01 to 2021-06-30 | −$3.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2021-01-01 to 2021-06-30 | −$9.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-04-01 to 2021-06-30 | $1.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2021-01-01 to 2021-06-30 | $3.6k | us-gaap:InterestExpense |
| Net income | 3 months, 2021-04-01 to 2021-06-30 | −$3.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2021-01-01 to 2021-06-30 | −$9.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-04-01 to 2021-06-30 | −$0.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2021-01-01 to 2021-06-30 | −$0.08 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2021-01-01 to 2021-06-30 | −$6.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2021-06-30 | $34.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-06-30 | $34.7m | us-gaap:AssetsCurrent |
| Total assets | at 2021-06-30 | $35.2m | us-gaap:Assets |
| Current liabilities | at 2021-06-30 | $2.1m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2021-06-30 | $32.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1174940/000149315221020152/form10-q.htm

Filed Aug 16, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-020152. Last ingested by Listed: Nov 13, 2026, 16:40 ET. No prices; not investment advice.
